share_log

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K:诺和诺德-股票回购计划
美股SEC公告 ·  09/09 11:15

Moomoo AI 已提取核心信息

Novo Nordisk A/S, a leading global healthcare company, has announced the progress of its share repurchase program on September 9, 2024. The program, which began on August 7, 2024, is part of a larger 12-month share repurchase plan initiated on February 6, 2024, with a total budget of up to DKK 20 billion. As of September 6, 2024, Novo Nordisk has repurchased 12,023,313 B shares at an average price of DKK 880.98 per share, amounting to DKK 10,592,256,521. The current phase of the program aims to repurchase B shares for up to DKK 2.4 billion between August 7 and November 4, 2024. Since the last announcement, 956,187 B shares have been acquired for a total of DKK 864,550,471. Novo Nordisk now holds 13,351,944 B shares as treasury shares, which is 0.3% of the share capital. The company's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
Novo Nordisk A/S, a leading global healthcare company, has announced the progress of its share repurchase program on September 9, 2024. The program, which began on August 7, 2024, is part of a larger 12-month share repurchase plan initiated on February 6, 2024, with a total budget of up to DKK 20 billion. As of September 6, 2024, Novo Nordisk has repurchased 12,023,313 B shares at an average price of DKK 880.98 per share, amounting to DKK 10,592,256,521. The current phase of the program aims to repurchase B shares for up to DKK 2.4 billion between August 7 and November 4, 2024. Since the last announcement, 956,187 B shares have been acquired for a total of DKK 864,550,471. Novo Nordisk now holds 13,351,944 B shares as treasury shares, which is 0.3% of the share capital. The company's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
全球领先的医疗保健公司诺和诺德(Novo Nordisk A/S)于2024年9月9日宣布了其股票回购计划的进展。该计划于2024年8月7日开始,是2024年2月6日启动的较大规模的为期12个月的股票回购计划的一部分,总预算高达200亿丹麦克朗(DKK)。截至2024年9月6日,诺和诺德已以平均每股880.98丹麦克朗的价格回购了120233130亿股,总计金额为105,922,565,521丹麦克朗。当前阶段的计划旨在于2024年8月7日至11月4日回购多达24亿丹麦克朗的b股。自上次公告以来,已获得了9561870亿股,总计金额为864,550,471丹麦克朗。诺和诺德目前持有133519440亿股作为库存股,占股本的0.3%。该公司的股票在纳斯达克哥本哈根交易,其ADR在纽约证券交易所交易。
全球领先的医疗保健公司诺和诺德(Novo Nordisk A/S)于2024年9月9日宣布了其股票回购计划的进展。该计划于2024年8月7日开始,是2024年2月6日启动的较大规模的为期12个月的股票回购计划的一部分,总预算高达200亿丹麦克朗(DKK)。截至2024年9月6日,诺和诺德已以平均每股880.98丹麦克朗的价格回购了120233130亿股,总计金额为105,922,565,521丹麦克朗。当前阶段的计划旨在于2024年8月7日至11月4日回购多达24亿丹麦克朗的b股。自上次公告以来,已获得了9561870亿股,总计金额为864,550,471丹麦克朗。诺和诺德目前持有133519440亿股作为库存股,占股本的0.3%。该公司的股票在纳斯达克哥本哈根交易,其ADR在纽约证券交易所交易。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息